NNVC vs RARE · $22.2M cap vs rev $350.0M
NanoViricides Inc (NNVC) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
NanoViricides Inc (NNVC) is a biotechnology company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported NNVC revenue for 2026-03-31 was $0. Net income was -$6.0M. NNVC currently screens at market cap $22.2M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
NNVC currently screens at market cap $22.2M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the NNVC and RARE stock pages for the full models.
Not investment advice.